Tobias F. Dreyer

Ismaninger Str. 22
Munich, BY 81675, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications

High uPAR and Low miR-221 Expression Predict Poor Disease-Free Survival in Triple-Negative Breast Cancer.

High uPAR and Low miR-221 Expression Predict Poor Disease-Free Survival in Triple-Negative Breast Cancer.

Journal: Pathophysiology : the official journal of the International Society for Pathophysiology
Published: February 06, 2026

Development of kallikrein-related peptidase 7 (KLK7) inhibitors and use in a species-adapted model for ovarian cancer.

Development of kallikrein-related peptidase 7 (KLK7) inhibitors and use in a species-adapted model for ovarian cancer.

Journal: Biological chemistry
Published: December 19, 2025

Drug Discovery Strategies for Kallikrein-Related Peptidases.

Drug Discovery Strategies for Kallikrein-Related Peptidases.

Journal: International journal of molecular sciences
Published: November 15, 2025

Keratin 19 as a prognostic marker and contributing factor of metastasis and chemoresistance in high-grade serous ovarian cancer.

Keratin 19 as a prognostic marker and contributing factor of metastasis and chemoresistance in high-grade serous ovarian cancer.

Journal: Molecular oncology
Published: October 25, 2025

KLK7 overexpression promotes an aggressive phenotype and facilitates peritoneal dissemination in colorectal cancer cells.

KLK7 overexpression promotes an aggressive phenotype and facilitates peritoneal dissemination in colorectal cancer cells.

Journal: FEBS open bio
Published: July 18, 2025

Collaborative framework on responsible AI in LLM-driven CDSS for precision oncology leveraging real-world patient data.

Collaborative framework on responsible AI in LLM-driven CDSS for precision oncology leveraging real-world patient data.

Journal: NPJ precision oncology
Published: June 21, 2025

Two-dimensional analysis of plasma-derived extracellular vesicles to determine the HER2 status in breast cancer patients.

Two-dimensional analysis of plasma-derived extracellular vesicles to determine the HER2 status in breast cancer patients.

Journal: Breast cancer research : BCR
Published: January 14, 2025

Expert-Guided Large Language Models for Clinical Decision Support in Precision Oncology.

Expert-Guided Large Language Models for Clinical Decision Support in Precision Oncology.

Journal: JCO precision oncology
Published: October 30, 2024

PARP inhibitor-induced anti-tumour chemokine response is suppressed by dipeptidyl peptidase 4 (DPP4) in ovarian cancer.

PARP inhibitor-induced anti-tumour chemokine response is suppressed by dipeptidyl peptidase 4 (DPP4) in ovarian cancer.

Journal: British journal of cancer
Published: September 29, 2024

Large language models-enabled digital twins for precision medicine in rare gynecological tumors.

Large language models-enabled digital twins for precision medicine in rare gynecological tumors.

Journal: NPJ digital medicine
Published: August 29, 2024

The chemokine CX3CL1 promotes intraperitoneal tumour growth despite enhanced T-cell recruitment in ovarian cancer.

The chemokine CX3CL1 promotes intraperitoneal tumour growth despite enhanced T-cell recruitment in ovarian cancer.

Journal: Neoplasia (New York, N.Y.)
Published: July 11, 2024

Association of high miR-27a, miR-206, and miR-214 expression with poor patient prognosis and increased chemoresistance in triple-negative breast cancer.

Association of high miR-27a, miR-206, and miR-214 expression with poor patient prognosis and increased chemoresistance in triple-negative breast cancer.

Journal: American journal of cancer research
Published: January 23, 2023
Showing 1-12 of 37

Last Updated: 09/26/2026